| NAME | : | Idelalisib |
| BOBOT | : | 415.432 |
| RUMUS | : | C22H18FN7O |
| THERAPEUTIC INDC | : | Idelalisib is indicated in the treatment of chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed ... |
| CATEGORIES | : | Class Ia Phosphatidylinositol 3-Kinase, antagonists & inhibitors / Enzyme Inhibitors / Kinase Inhibitor |
| STRUCTURE | : |  |